• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Team studies smarter automatic defibrillator

Bioengineer by Bioengineer
March 19, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

SAN ANTONIO — Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators (AICDs) that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival in patients who are at risk for sudden cardiac death.

AICDs administer shocks based on data from intra-cardiac electrocardiograms (ECGs) obtained from leads that measure the heart’s electrical activity. However, do these devices receive enough information to shock accurately in all cases?

“Existing systems in patients primarily sense the ECG,” said Marc D. Feldman, M.D., professor of cardiology at UT Health San Antonio. “They don’t sense blood pressure or stroke volume — how much blood is being pumped out of the heart. Since physicians in the emergency room measure blood pressure and stroke volume at the time of an abnormal heart rhythm before deciding to shock the patient, we believe AICDs should do the same.”

Dr. Feldman worked with UT Austin electrical engineers Jonathan W. Valvano, Ph.D., and John A. Pearce, Ph.D., to help create a smarter implantable defibrillator.

Results presented in New Orleans

On March 17 at the American College of Cardiology’s 68th Annual Scientific Session in New Orleans, Dr. Valvano and Dr. Feldman’s recent graduate student, Lucas Holt, Ph.D., presented study results from his Ph.D. project. The study, conducted in large animals with heart failure, showed that a reprogrammed AICD can accurately track stroke volume in addition to ECG readings.

“In this study, we replicated what happens in humans,” Dr. Feldman said. “The animals had heart failure and implanted defibrillator leads. We proved that we could use the same leads and modify the information extracted by these leads to measure stroke volume accurately.”

The researchers have not studied whether the updated defibrillator eliminates unnecessary shocks, Dr. Feldman said. The hope is that, with complete information, shocks will be delivered only when needed or withheld when not needed.

More accurate identification of when to shock

“We believe people may be able to avoid unnecessary and traumatic shocks when the stroke volume is normal,” Dr. Feldman said. “But when the stroke volume is low, the device will more accurately identify patients who need to be shocked. So it will help in either fashion.”

JACC: Clinical Electrophysiology, a journal of the American College of Cardiology, published the findings concurrently with Dr. Holt’s presentation in New Orleans. He spoke during a session titled “Highlighted Original Research.” “Usually this is done only when something is deemed important to the journal reviewers and to the American College of Cardiology,” Dr. Feldman said.

Manoj M. Panday, M.D., head of the Section of Cardiac Electrophysiology at UT Health San Antonio, treats defibrillator patients on a daily basis. He was not involved directly in the current studies, but said: “Detection of changes in stroke volume may help to prevent inappropriate shocks and improve the ability of the device to deliver therapy for clinically significant arrhythmias that need to be treated.”

In a previous study published in the journal Heart Rhythm in October 2017, the team showed that a reprogrammed automatic defibrillator could serve as a warning system of congestive heart failure in human patients.

###

This research is supported by a $2 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Additional support was from the Texas Emerging Technology Fund. Dr. Feldman is the Janey Briscoe Distinguished Professor of Medicine in the Joe R. and Teresa Lozano Long School of Medicine.

Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.

The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio®, is one of the country’s leading health sciences universities. With missions of teaching, research, healing and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit http://www.uthscsa.edu.

Media Contact
Will Sansom
[email protected]

Related Journal Article

https://news.uthscsa.edu/team-studies-smarter-automatic-defibrillator/
http://dx.doi.org/10.1016/j.jacep.2019.01.019

Tags: CardiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

February 7, 2026

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.